Back to Search
Start Over
Prognostic Index for Survival in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Third-Generation Agents.
- Source :
- Chemotherapy (0009-3157); Jun2017, Vol. 62 Issue 4, p239-245, 7p
- Publication Year :
- 2017
-
Abstract
- We retrospectively evaluated clinical data from patients with advanced non-small-cell lung cancer (NSCLC) treated with third-generation chemotherapy agents prior to treatment, to determine a reliable method for predicting prognosis in such patients. We analyzed 100 patients who received thirdgeneration agents (paclitaxel, docetaxel, gemcitabine, irinotecan, and vinorelbine) for the treatment of advanced NSCLC. Factors significantly related to prognosis were evaluated using the Cox regression model, and the prognostic index (PI) was determined by combining these factors. The mean follow-up duration was 12.6 months (0.2-67.0 months). Multivariate analysis identified pleural effusion, absolute neutrophil count (ANC), and C-reactive protein (CRP) level as significant factors that independently contribute to prognosis in patients with advanced NSCLC treated with third-generation agents ( p < 0.05). The PI was calculated using these 3 factors, according to the following formula: PI = 0.581 × pleural effusion + 0.125 × ANC + 0.105 × CRP. The death rate in the group with the highest PI scores was significantly higher than in the group with the lowest scores ( p < 0.001). Pleural effusion, ANC, and CRP level were the most important factors that contributed to prognosis following chemotherapy with third-generation agents in patients with advanced NSCLC. The PI is suggested to be an appropriate index to predict the prognosis of patients with NSCLC. [ABSTRACT FROM AUTHOR]
- Subjects :
- LUNG cancer
CANCER chemotherapy
PACLITAXEL
MULTIVARIATE analysis
PLEURAL effusions
Subjects
Details
- Language :
- English
- ISSN :
- 00093157
- Volume :
- 62
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Chemotherapy (0009-3157)
- Publication Type :
- Academic Journal
- Accession number :
- 123626676
- Full Text :
- https://doi.org/10.1159/000468508